Author Relationships With Industry and Other Entities (Relevant) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Committee Member Employer/Title Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section Number* Glenn N. Levine (Chair) Baylor College of Medicine Professor of Medicine; Director, Cardiac Care Unit None None None None None None None Eric R. Bates (Vice Chair) University of Michigan Professor of Medicine Bristol-Myers Squibb Daiichi-Sankyo Datascope Eli Lilly Merck Sanofi-aventis None None None None None 5.7.2 James C. Blankenship (Vice Chair) Geisinger Medical Center Director of Cardiology and Cardiac Catheterization Laboratories None None None Abiomed AstraZeneca Boston Scientific Conor Medsystems Kai Pharmaceutical Schering-Plough None None 2.1 Steven R. Bailey University of Texas Medical Center-Professor of Medicine and Radiology Volcano None None Boston Scientific None None 5.4.1 John A. Bittl Munroe Heart-Interventional Cardiologist None None None None None None None Bojan Cercek Cedars-Sinai Medical Center-Director, Coronary Care Unit None None None None None None None Charles E. Chambers Penn State Milton S. Hershey Medical Center-Professor of Medicine and Radiology None None None None None None None Stephen G. Ellis Cleveland Clinic Foundation-Section Head, Invasive and Interventional Cardiology Abbott Vascular Boston Scientific Cordis Daiichi-Sankyo Eli Lilly None None Abbott Vascular None None 2.2 Robert A. Guyton Emory Clinic, Inc.-Professor and Chief, Division of Cardiothoracic Surgery None None None Edwards Lifesciences None None 2.1 Steven M. Hollenberg Cooper University Hospital-Director, Coronary Care Unit Eisai None None None None None 5.7.4.3 Umesh N. Khot CV Research Innovations, LLC-President/CEO None None Merck None None None 4.6 Richard A. Lange University of Texas Health Science Center at San Antonio-Professor of Medicine None None None None None None None (Continued) Levine et al 2011 ACCF/AHA/SCAI PCI Guideline e643 Appendix 1. Continued Committee Member Employer/Title Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section Number* Laura Mauri Brigham and Women s Hospital-Associate Professor of Medicine, Harvard Medical School Abbott Conor Medsystems (Johnson & Johnson) Cordis Medtronic None None Lutonix Abbott Abiomed Boston Scientific Bristol-Myers Squibb Conor Medsystems Cordis Daiichi-Sankyo Eli Lilly Medtronic Cardiovascular Sanofi-aventis Defendant, Conor, interpretation of clinical trial Roxana Mehran Columbia University Medical Center-Associate Professor of Medicine; Director, Data Coordinating Analysis Center Abbott Vascular Abiomed AlphaMedical AstraZeneca Bracco BMS/ sanofi-aventis DataScope Eli Lilly/Daichii-Sankyo Guerbet The Medicines Company Medtronic Vascular St. Jude None None None None None 4.7 Issam D. Moussa Mayo Clinic-Professor of Medicine; Chair, Division of Cardiovascular Diseases None None None None None None None Debabrata Mukherjee Texas Tech University-Chief, Cardiovascular Medicine None None None None None None None Brahmajee K. Nallamothu University of Michigan-Assistant Professor of Medicine None None None None None None None Henry H. Ting Mayo Clinic-Professor of Medicine; Assistant Dean for Quality None None None None None None None This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. 